CN110664643A - Polypeptide essence with multiple-effect whitening effect and preparation method thereof - Google Patents
Polypeptide essence with multiple-effect whitening effect and preparation method thereof Download PDFInfo
- Publication number
- CN110664643A CN110664643A CN201911040758.7A CN201911040758A CN110664643A CN 110664643 A CN110664643 A CN 110664643A CN 201911040758 A CN201911040758 A CN 201911040758A CN 110664643 A CN110664643 A CN 110664643A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- aloe
- weight
- whitening effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000002087 whitening effect Effects 0.000 title claims abstract description 58
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 24
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 24
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 24
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 136
- 229940069521 aloe extract Drugs 0.000 claims abstract description 32
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 36
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 30
- RWZYAGGXGHYGMB-UHFFFAOYSA-N o-aminobenzenecarboxylic acid Natural products NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 claims description 25
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 21
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims description 21
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 19
- QRYRORQUOLYVBU-VBKZILBWSA-N Carnosic acid Natural products CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 claims description 18
- 108010087806 Carnosine Proteins 0.000 claims description 18
- CQOVPNPJLQNMDC-UHFFFAOYSA-N N-beta-alanyl-L-histidine Natural products NCCC(=O)NC(C(O)=O)CC1=CN=CN1 CQOVPNPJLQNMDC-UHFFFAOYSA-N 0.000 claims description 18
- 229940044199 carnosine Drugs 0.000 claims description 18
- CQOVPNPJLQNMDC-ZETCQYMHSA-N carnosine Chemical compound [NH3+]CCC(=O)N[C@H](C([O-])=O)CC1=CNC=N1 CQOVPNPJLQNMDC-ZETCQYMHSA-N 0.000 claims description 18
- 239000000706 filtrate Substances 0.000 claims description 18
- 239000011570 nicotinamide Substances 0.000 claims description 18
- 229960003966 nicotinamide Drugs 0.000 claims description 18
- 235000005152 nicotinamide Nutrition 0.000 claims description 18
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 15
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 15
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 15
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 15
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 15
- 239000011668 ascorbic acid Substances 0.000 claims description 15
- 229960005070 ascorbic acid Drugs 0.000 claims description 15
- 235000010323 ascorbic acid Nutrition 0.000 claims description 15
- 239000004359 castor oil Substances 0.000 claims description 15
- 235000019438 castor oil Nutrition 0.000 claims description 15
- 229920001577 copolymer Polymers 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 15
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 15
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 15
- 235000014676 Phragmites communis Nutrition 0.000 claims description 14
- 244000137827 Rumex acetosa Species 0.000 claims description 13
- 235000005291 Rumex acetosa Nutrition 0.000 claims description 13
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 claims description 13
- 235000011399 aloe vera Nutrition 0.000 claims description 12
- 239000003906 humectant Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241001116389 Aloe Species 0.000 claims description 11
- KNFLNGRLKALWRF-LDXSYGEZSA-N CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)CC1=CC=CC=C1 KNFLNGRLKALWRF-LDXSYGEZSA-N 0.000 claims description 10
- 239000004386 Erythritol Substances 0.000 claims description 10
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims description 10
- -1 acyl anthranilic acid Chemical compound 0.000 claims description 10
- 239000001180 angelica archangelica l. root extract Substances 0.000 claims description 10
- 229940009714 erythritol Drugs 0.000 claims description 10
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims description 10
- 235000019414 erythritol Nutrition 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 10
- 239000006210 lotion Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 244000241838 Lycium barbarum Species 0.000 claims description 9
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 9
- 240000001439 Opuntia Species 0.000 claims description 9
- 235000013389 Opuntia humifusa var. humifusa Nutrition 0.000 claims description 9
- 235000013399 edible fruits Nutrition 0.000 claims description 9
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 claims description 9
- 229940051810 licorice root extract Drugs 0.000 claims description 9
- 235000020725 licorice root extract Nutrition 0.000 claims description 9
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 8
- ZJBHFQKJEBGFNL-UHFFFAOYSA-N methylsilanetriol Chemical compound C[Si](O)(O)O ZJBHFQKJEBGFNL-UHFFFAOYSA-N 0.000 claims description 8
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 8
- 229940089952 silanetriol Drugs 0.000 claims description 8
- 102000004190 Enzymes Human genes 0.000 claims description 7
- 108090000790 Enzymes Proteins 0.000 claims description 7
- 235000015468 Lycium chinense Nutrition 0.000 claims description 7
- 239000009188 angelicae sinensis extract Substances 0.000 claims description 7
- 238000007599 discharging Methods 0.000 claims description 7
- 229940088598 enzyme Drugs 0.000 claims description 7
- 230000000149 penetrating effect Effects 0.000 claims description 7
- 229940084801 salvia miltiorrhiza root extract Drugs 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 241000219357 Cactaceae Species 0.000 claims description 6
- 230000000593 degrading effect Effects 0.000 claims description 6
- 244000273256 Phragmites communis Species 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000004537 pulping Methods 0.000 claims description 5
- 229940084750 sophora flavescens root extract Drugs 0.000 claims description 5
- 238000009210 therapy by ultrasound Methods 0.000 claims description 5
- PJYONPGZTHDDJM-UHFFFAOYSA-N 2-amino-3-methyl-4h-imidazol-5-one;hydron;chloride Chemical compound Cl.CN1CC(=O)N=C1N PJYONPGZTHDDJM-UHFFFAOYSA-N 0.000 claims description 4
- 241000246044 Sophora flavescens Species 0.000 claims description 4
- 244000223014 Syzygium aromaticum Species 0.000 claims description 4
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 4
- 229940084830 artemisia capillaris flower extract Drugs 0.000 claims description 4
- 229940087068 glyceryl caprylate Drugs 0.000 claims description 4
- 230000003204 osmotic effect Effects 0.000 claims description 4
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 claims description 4
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 claims description 3
- 229940100573 methylpropanediol Drugs 0.000 claims description 3
- 239000004382 Amylase Substances 0.000 claims description 2
- 108010065511 Amylases Proteins 0.000 claims description 2
- 102000013142 Amylases Human genes 0.000 claims description 2
- 108010059892 Cellulase Proteins 0.000 claims description 2
- 108010059820 Polygalacturonase Proteins 0.000 claims description 2
- 235000019418 amylase Nutrition 0.000 claims description 2
- 229940106157 cellulase Drugs 0.000 claims description 2
- 108010093305 exopolygalacturonase Proteins 0.000 claims description 2
- 240000006766 Cornus mas Species 0.000 claims 2
- 239000000126 substance Substances 0.000 abstract description 4
- 241001523681 Dendrobium Species 0.000 abstract description 2
- 229940045811 echinacea purpurea extract Drugs 0.000 abstract description 2
- 239000000419 plant extract Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 48
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 36
- 230000000694 effects Effects 0.000 description 19
- 230000000052 comparative effect Effects 0.000 description 12
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 210000002966 serum Anatomy 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 7
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 7
- 229960004705 kojic acid Drugs 0.000 description 7
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 7
- 241000209020 Cornus Species 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- 102000003425 Tyrosinase Human genes 0.000 description 6
- 108060008724 Tyrosinase Proteins 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 244000248557 Ophiopogon japonicus Species 0.000 description 5
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 5
- 230000006641 stabilisation Effects 0.000 description 5
- 238000011105 stabilization Methods 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 229930195210 Ophiopogon Natural products 0.000 description 4
- 108010077895 Sarcosine Proteins 0.000 description 4
- 230000036564 melanin content Effects 0.000 description 4
- 229940043230 sarcosine Drugs 0.000 description 4
- 230000002195 synergetic effect Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 241000219784 Sophora Species 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000007664 blowing Methods 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 210000002752 melanocyte Anatomy 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 235000004727 Opuntia ficus indica Nutrition 0.000 description 2
- 240000009297 Opuntia ficus-indica Species 0.000 description 2
- 206010040880 Skin irritation Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 2
- 238000010009 beating Methods 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 238000005282 brightening Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 239000002932 luster Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004792 oxidative damage Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000036556 skin irritation Effects 0.000 description 2
- 231100000475 skin irritation Toxicity 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241000382455 Angelica sinensis Species 0.000 description 1
- 102000010637 Aquaporins Human genes 0.000 description 1
- 108010063290 Aquaporins Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000759833 Cornus officinalis Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000009066 Hyaluronoglucosaminidase Human genes 0.000 description 1
- 235000015463 Lycium carolinianum Nutrition 0.000 description 1
- 101150004219 MCR1 gene Proteins 0.000 description 1
- 240000003394 Malpighia glabra Species 0.000 description 1
- 235000014837 Malpighia glabra Nutrition 0.000 description 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 1
- 101710200814 Melanotropin alpha Proteins 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 241001050807 Rumex occidentalis Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000005016 dendritic process Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000003446 ligand Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 150000002731 mercury compounds Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037393 skin firmness Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 238000011895 specific detection Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
Abstract
The invention discloses polypeptide essence with multiple-effect whitening effect and a preparation method thereof. Meanwhile, the high-concentration functional substances are adopted to achieve the efficient whitening effect, and the aloe extract, the dendrobium stem extract, the fructus lycii extract, the echinacea purpurea extract and other plant extracts are compounded to form a stability maintaining system, so that the skin is prevented from being damaged by the high-concentration whitening functional substances, and the skin is efficiently whitened in a safe and stable environment.
Description
Technical Field
The invention belongs to the technical field of cosmetics, and particularly relates to polypeptide essence with a multi-effect whitening effect and a preparation method thereof.
Background
Melanocytes, one of the important constituent cells of the skin, are dendritic processes through which melanin formed within the cell is transported into the cells of the stratum corneum. It is prepared by the following steps of 1: the 36 ratio constitutes one epidermal unit with keratinocytes, about 1500 per square millimeter. Melanin has effects of protecting skin against ultraviolet, tyrosine is used as main raw material for preparing melanin, tyrosinase is the main rate-limiting enzyme for converting tyrosine into melanin, and catalytic efficiency is 6X1022The instant black coating effect can be achieved; in addition, melanin is transferred to keratinocytes and transferred to surface cells layer by layer to form apparent skin color; meanwhile, the horny layer of epidermis is too thick and does not appear glossy, which is one of the reasons why the skin is not fair enough.
In the Chinese society, which is believed to be 'white covering ugly', the health whitening problem of women is always a beauty problem which is concerned about. Ancient palace beauty treatment uses mercury compounds to whiten the skin, and after 6 weeks of use, the whitening effect is obvious. With the advance of science and technology, people deepen the understanding of the extreme toxicity of mercury to human bodies and have been banned for a long time. At present, one of the most effective skin whitening actives is hydroquinone, i.e., hydroquinone, which acts to inhibit melanin formation by inhibiting the activity of tyrosinase, but hydroquinone, which has a small molecular weight, destroys melanocytes, and may cause skin irritation and contact dermatitis. In addition, hydroquinone is also classified as a potential carcinogenic substance. Therefore, hydroquinone is subject to strict regulations in most countries of the world and is prohibited from being used as a cosmetic ingredient.
At present, in order to make a short-term profit, some illegal merchants add glucocorticoid to cosmetics such as facial masks. The whitening and firming effect can be generated in a short time, but the long-term use of the whitening and firming agent has very serious consequences on the skin of a human. However, since the product design of whitening mind and urgent work is urgently required for a long time, many whitening skin care products are in serious misdirection, pursue rapid whitening, depart from the track of natural growth rule and scientific rule, and the whitening products with large toxic and side effects mostly cause skin dependence and fall into a vicious circle state to damage the skin health. In recent years, therefore, safe whitening skin care products are gradually recognized and accepted by the most distant women. At present, whitening products on the market are continuously emerging, and most of the products adopt nicotinamide for whitening, which can quickly obtain whitening effect by blocking the transfer of melanin to the surface layer, but can quickly rebound once being stopped, can not systematically inhibit the growth chain of the melanin, and are difficult to realize the effects of real whitening, spot lightening, skin color balancing and skin luster recovery. Therefore, it is imperative to find an efficient and safe whitening regimen.
Disclosure of Invention
In order to solve the problems, the invention provides a polypeptide essence with multiple-effect whitening effect and a preparation method thereof, and the invention aims to provide the polypeptide essence with the functions of point-line-surface and multi-direction whitening, wherein the polypeptide essence is synergistic by using multiple whitening mechanisms and has high whitening efficiency.
The invention is realized by the following technical scheme:
a polypeptide essence with multiple-effect whitening effect is composed of the following raw materials in parts by weight:
the preferable polypeptide essence with the multiple-effect whitening effect is prepared from the following raw materials in parts by weight: 68.1 parts of aloe extract, 1 part of reed extract, 1 part of licorice root extract, 1 part of angelica root extract, 1 part of salvia miltiorrhiza root extract, 1 part of dogwood fruit extract, 1 part of wolfberry root extract, 0.7 part of radix ophiopogonis extract, 1 part of rumex acetosa extract, 0.6 part of twisted cactus stem extract, 0.02 part of sophora flavescens ait root extract, 3 parts of 1, 2-pentanediol, nonapeptide-16 parts, 2 parts of carnosine, 0.3 part of ascorbic acid, 3 parts of nicotinamide, 3 parts of osmotic humectant, 2 parts of linlan lotion, 3 parts of rhamnose silanol, 0.8 part of trehalose, 1 part of dihydroavenoyl anthranilic acid, 0.1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer and 0.1 part of PEG-40 hydrogenated castor oil.
Further, the rhamnosilanol is a mixture of 0.3 parts by weight of silanetriol, 2.35 parts by weight of rhamnose and 20 parts by weight of methylpropanediol.
Further, the permeable humectant is a mixture of erythritol and creatinine HCl, and the mass ratio of the erythritol to the creatinine HCl is 100: 1.
The essence also comprises 0.1-1 weight part of a mixture of artemisia capillaris flower extract, clove flower extract and glyceryl caprylate; the mass ratio of the artemisia capillaris flower extract to the clove flower extract to the glyceryl caprylate is 20-25: 10-15: 3-5.
Further, the preparation method of the aloe extract comprises the following steps:
s1, selecting ripe aloe, cleaning, and pulping in a sealed environment;
s2, adding 5-8 times of 85-98% 1, 3-propylene glycol solution as solvent into the aloe pulp, performing ultrasonic treatment at 35-45 deg.C for 20min, and filtering to obtain the first filtrate;
s3, adding 10 parts by weight of distilled water into the obtained filter residue, adding degrading enzyme, stirring uniformly, standing for 30min, and filtering to obtain a second filtrate;
s4, mixing the first filtrate and the second filtrate, and mixing to obtain the aloe extract.
Further, the degrading enzyme is a mixture of 0.15-0.2 weight part of cellulase, 0.023-0.028 weight part of pectinase and 0.015-0.018 weight part of amylase.
The invention also discloses a preparation method of the polypeptide essence with the multi-effect whitening effect, which comprises the following steps:
a1, mixing Aloe extract, Phragmites communis extract and Glycyrrhrizae radix extract;
a2, mixing radix Angelicae sinensis extract, radix Salviae Miltiorrhizae extract, fructus Corni extract and fructus Lycii extract at room temperature;
a3, premixing 1, 2-pentanediol, nicotinamide and PEG-40 hydrogenated castor oil; and adding the mixture obtained in the step A1 and the step A2, mixing and stirring uniformly, adding nonapeptide-1, carnosine, a rumex acetosa extract, ascorbic acid, a penetrating humectant, a linlan lotion, rhamnose silanol, trehalose, a radix ophiopogonis extract, a twisted cactus stem extract, a sophora flavescens root extract, dihydroavenyl anthranilic acid and an acrylic acid (ester)/C12-22 alkanol methacrylate copolymer, stirring uniformly at normal temperature, standing stably and discharging.
The invention has the beneficial effects that:
1. the invention takes the polypeptide as the core and compounds various functional raw materials, inhibits the activity of the tyrosinase, reduces the synthesis of melanin, blocks the transfer of the generated melanin to surface cells, reduces the generated melanin, improves skin microcirculation and the like, and performs whitening from point and line surfaces in multiple directions under the synergistic action of various whitening mechanisms, thereby enabling the skin to be transparent and bright from inside to outside. Meanwhile, the high-concentration functional substances are adopted to achieve the efficient whitening effect, and the aloe extract, the dendrobium stem extract, the fructus lycii extract, the echinacea purpurea extract and other plant extracts are compounded to form a stability maintaining system, so that the skin is prevented from being damaged by the high-concentration whitening functional substances, and the skin is efficiently whitened in a safe and stable environment.
2. The nonapeptide-1 of the invention blocks the activation of tyrosinase and reduces the generation of melanin by competitively antagonizing the combination of natural ligand melanocyte stimulating hormone alpha-MSH and receptor MCR-1 on melanocyte; the small molecular polypeptide is used as an endogenous active substance, is easy to absorb, and has high affinity and high efficiency with skin. Meanwhile, the addition of the carnosine prevents peroxidation in the skin, reduces the oxidative damage of the skin, promotes the synthesis of collagen, protects skin cells from DNA damage caused by ultraviolet irradiation, and prevents the damage of infrared rays. The skin wrinkle and dullness are improved in many aspects, the skin firmness and glossiness are improved, and the young and healthy skin is recovered. The aloe extract, the reed extract, the licorice root extract, the angelica root extract and other extracts are carefully matched, so that the aloe extract, the reed extract, the licorice root extract, the angelica root extract and other extracts can effectively resist and eliminate free radicals, inhibit hyaluronidase and tyrosinase, and have good antioxidant activity; the skin care product can also effectively improve the dull state of the skin caused by oxidative damage, effectively improve the microcirculation blood flow of the skin, improve the microcirculation, promote the absorption of nonapeptide-1 and nicotinamide, and further improve the effects of whitening and brightening, thereby comprehensively improving the skin state. Has effects of mildly soothing skin; can also promote the synthesis of aquaporins, has the effect of deeply moisturizing, and makes the skin emit healthy and natural luster, and the skin be transparent and glossy from inside to outside.
3. The aloe extract is extracted by a method of synergy of propylene glycol hydrosolvent, ultrasonic waves and enzymolysis, so that the extraction efficiency is improved, high-temperature extraction is avoided, the phenomenon of inactivation of the extract at high temperature is reduced, meanwhile, pectin is decomposed by the enzymolysis, the viscosity is reduced, the juice yield is improved, the skin feel is improved, and meanwhile, cellulose is decomposed into oligosaccharide and polysaccharide, the molecular weight is reduced, and the absorption by the skin is facilitated. The aloe extract is rich in polysaccharide, barbaloin, amino acid, various organic acids, trace elements and the like, has the effects of relieving, repairing and improving reddened skin and enhancing cell activity besides the basic moisturizing and moisturizing effect, and can play a synergistic effect with polypeptide and nicotinamide to enhance the whitening effect. The propylene glycol is used as an extraction solvent II, so that ethanol is avoided, the skin is prevented from being stimulated by a large amount of residual ethanol, the dissolution of effective components can be increased by the propylene glycol, and the skin care effects such as moisture retention and the like can be achieved.
4. The invention plays a role in balancing whitening and brightening through multi-azimuth combination of point line surfaces, and points are as follows: ascorbic acid reduces already produced melanin, line: linlan lotion smooth and fine lines, make skin transparent and bright, face: the extracts of nonapeptide-1, radix Angelicae sinensis, and Glycyrrhrizae radix extract have effects of inhibiting activity of tyrosinase and improving skin color.
5. The cold preparation method is adopted to prepare the essence, so that the inactivation of active substances caused by improper temperature is completely avoided, meanwhile, no production water is added in the whole preparation process, a large amount of aloe extract is used for substitution, more active substances are injected into the formula, the moisture is preserved, the water is supplemented, and the skin care effect is better.
Drawings
FIG. 1 is a schematic diagram of the evaluation of apparent chromaticity of a blank control group;
FIG. 2 is a schematic diagram showing the evaluation of apparent color of kojic acid solution
FIG. 3 is a schematic diagram showing the evaluation of the apparent chromaticity of the essence prepared in example 3;
FIG. 4 is a graph showing the evaluation of the apparent brightness of the essence prepared in example 3;
fig. 5 is a graph illustrating the melanin content of the serum prepared in example 3.
Detailed Description
In order to better understand the present invention, the following examples are further described, which are only used to explain the present invention and do not limit the present invention.
The following examples are intended to illustrate the invention but are not intended to limit the scope of the invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are commercially available products. Purchase factories offering commercially available products
Silanetriol, rhamnose and methylpropanediol are from acerola, france; the extract of Rumex occidentalis is from Lucas Meier, USA; ascorbic acid is from Shanghai national drug group, Inc.; the osmotic moisturizer, erythritol, and carnosine HCl are from france semama; the radix Sophorae Flavescentis extract is obtained from Sienna Lingfeng Biotechnology GmbH; the Linlan Runlu, the stem extract of Opuntia ficus-indica, the root extract of Glycyrrhiza uralensis Fisch, the root extract of Angelica sinensis, the root extract of Salvia miltiorrhiza Bunge, the fruit extract of Cornus officinalis Sieb, the root extract of Lycium barbarum, the root extract of Ophiopogon japonicus, the stem extract of Opuntia ficus-indica and the root extract of Sophora flavescens are from vast Sen Biotech limited of Beijing.
Example 1
The preparation method of the aloe extract comprises the following steps:
a1, selecting ripe aloe, cleaning, and pulping in a sealed environment;
a2, adding 5 times of 85% 1, 3-propylene glycol solution as solvent into the aloe slurry, performing ultrasonic treatment at 35 deg.C for 20min, and filtering to obtain the first filtrate;
a3, adding 10 parts by weight of distilled water into the obtained filter residue, adding degrading enzyme, stirring uniformly, standing for 30min, and filtering to obtain a second filtrate;
a4, mixing the first and second filtrates, and mixing to obtain Aloe extract.
Best mode for carrying out the invention
The preparation method of aloe extract comprises:
a1, selecting ripe aloe, cleaning, and pulping in a sealed environment;
a2, adding 8 times of 98% 1, 3-propylene glycol solution as solvent into the aloe slurry, performing ultrasonic treatment at 45 deg.C for 20min, and filtering to obtain the first filtrate;
a3, adding 10 parts by weight of distilled water into the obtained filter residue, adding degrading enzyme, stirring uniformly, standing for 30min, and filtering to obtain a second filtrate;
a4, mixing the first and second filtrates, and mixing to obtain Aloe extract.
Best mode for carrying out the invention
A polypeptide essence with multiple-effect whitening effect is composed of the following raw materials in parts by weight: 50 parts of aloe extract; 0.5 part of reed extract; 0.5 part of licorice root extract; 0.5 part of angelica root extract; 0.5 part of salvia miltiorrhiza root extract; 0.5 part of dogwood fruit extract; 0.5 part of wolfberry root extract; 1 part of 1, 2-pentanediol; nonapeptide-18 parts; 2 parts of carnosine; 1 part of rumex acetosa extract; 0.5 part of ascorbic acid; 5 parts of nicotinamide; 3.5 parts of a penetrating humectant; 5 parts of rhamnose silanol; 10 parts of forest blue moistening lotion; 3 parts of rhamnose silanol; trehalose 0.3 parts, ophiopogon root extract 0.34 parts, prickly pear stem extract 0.35 parts, and flavescent sophora root extract 0.01 parts; 0.3 part of dihydrooat acyl anthranilic acid; 0.1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer; 0.1 part of PEG-40 hydrogenated castor oil.
The preparation method comprises the following steps
A1, mixing Aloe extract, Phragmites communis extract and Glycyrrhrizae radix extract;
a2, mixing radix Angelicae sinensis extract, radix Salviae Miltiorrhizae extract, fructus Corni extract and fructus Lycii extract at room temperature;
a3, premixing 1, 2-pentanediol, nicotinamide and PEG-40 hydrogenated castor oil; and adding the mixture obtained in the step A1 and the step A2, mixing and stirring uniformly, then adding nonapeptide-1, carnosine, a rumex acetosa extract, ascorbic acid, nicotinamide, erythritol, sarcosine HCl, silanetriol, rhamnose, methyl propylene glycol, linlan dew, trehalose, a radix ophiopogonis extract, a prickly pear stem extract, a radix sophorae flavescentis extract, dihydroavenyl anthranilic acid and an acrylic acid (ester)/C12-22 alkanol methacrylate copolymer, stirring uniformly at normal temperature, standing for stabilization, and discharging.
Example 4
A polypeptide essence with multiple-effect whitening effect is composed of the following raw materials in parts by weight: 68.1 parts of extract, 3 parts of 1, 2-pentanediol, 16 parts of nonapeptide, 2 parts of carnosine, 3 parts of nicotinamide and 2.5 parts of rumex acetosa extract; 0.3 part of ascorbic acid; 5 parts of nicotinamide; an osmotic humectant 3; 4 parts of rhamnose silanol; 2 parts of forest orchid hydrosol, 0.8 part of reed extract, 1 part of licorice root extract, 0.8 part of angelica root extract, 1 part of salvia miltiorrhiza root extract, 1 part of dogwood fruit extract, 0.5 part of boxthorn root extract, 1 part of trehalose, 1.2 parts of radix ophiopogonis extract, 0.88 part of prickly pear stem extract, 0.02 part of sophora flavescens ait root extract, 1 part of dihydroavenyl anthranilic acid, 0.1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer and 0.1 part of PEG-40 hydrogenated castor oil.
The preparation method comprises the following steps
A1, mixing Aloe extract, Phragmites communis extract and Glycyrrhrizae radix extract;
a2, mixing radix Angelicae sinensis extract, radix Salviae Miltiorrhizae extract, fructus Corni extract and fructus Lycii extract at room temperature;
a3, premixing 1, 2-pentanediol, nicotinamide and PEG-40 hydrogenated castor oil; and adding the mixture obtained in the step A1 and the step A2, mixing and stirring uniformly, then adding nonapeptide-1, carnosine, a rumex acetosa extract, ascorbic acid, nicotinamide, erythritol, sarcosine HCl, silanetriol, rhamnose, methyl propylene glycol, linlan dew, trehalose, a radix ophiopogonis extract, a prickly pear stem extract, a radix sophorae flavescentis extract, dihydroavenyl anthranilic acid and an acrylic acid (ester)/C12-22 alkanol methacrylate copolymer, stirring uniformly at normal temperature, standing for stabilization, and discharging.
Example 5
A polypeptide essence with multiple-effect whitening effect is composed of the following raw materials in parts by weight: 80 parts of aloe extract; 1 part of reed extract; 1 part of licorice root extract; 1 part of angelica root extract; 1 part of salvia miltiorrhiza root extract; 0.8 part of dogwood fruit extract; 1 part of wolfberry root extract; 5 parts of 1, 2-pentanediol; nonapeptide-18 parts; 2 parts of carnosine; 5 parts of nicotinamide; 1 part of rumex acetosa extract; 0.7 part of ascorbic acid; 5 parts of nicotinamide; 5 parts of a penetrating humectant; 5 parts of rhamnose silanol; 10 parts of forest blue moistening lotion; 1.5 parts of trehalose, 1.5 parts of radix ophiopogonis extract, 1.95 parts of twisted cactus stem extract and 0.05 part of sophora flavescens root extract; 2 parts of dihydrooat acyl anthranilic acid; 1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer; 1 part of PEG-40 hydrogenated castor oil.
The preparation method comprises the following steps
A1, mixing Aloe extract, Phragmites communis extract and Glycyrrhrizae radix extract;
a2, mixing radix Angelicae sinensis extract, radix Salviae Miltiorrhizae extract, fructus Corni extract and fructus Lycii extract at room temperature;
a3, premixing 1, 2-pentanediol, nicotinamide and PEG-40 hydrogenated castor oil; and adding the mixture obtained in the step A1 and the step A2, mixing and stirring uniformly, then adding nonapeptide-1, carnosine, a rumex acetosa extract, ascorbic acid, nicotinamide, erythritol, sarcosine HCl, silanetriol, rhamnose, methyl propylene glycol, linlan dew, trehalose, a radix ophiopogonis extract, a prickly pear stem extract, a radix sophorae flavescentis extract, dihydroavenyl anthranilic acid and an acrylic acid (ester)/C12-22 alkanol methacrylate copolymer, stirring uniformly at normal temperature, standing for stabilization, and discharging.
Comparative example 1
The preparation method of aloe extract comprises:
1. selecting mature aloe vera, cleaning, and pulping in a sealed environment.
2. Adding 8 times of water solvent as solvent into the aloe slurry, performing ultrasonic treatment at 35 deg.C for 20min, and filtering to obtain the first filtrate.
4. Adding 10 times of distilled water into the obtained filter residue, uniformly stirring, standing for 30min, and filtering to obtain a second filtrate.
5. Mixing the first filtrate and the second filtrate, and mixing to obtain Aloe extract.
Comparative example 2
50 parts of water; 0.5 part of reed extract; 0.5 part of licorice root extract; 0.5 part of angelica root extract; 0.5 part of salvia miltiorrhiza root extract; 0.5 part of dogwood fruit extract; 0.5 part of wolfberry root extract; 1 part of 1, 2-pentanediol; nonapeptide-18 parts; 2 parts of carnosine; 1 part of rumex acetosa extract; 0.5 part of ascorbic acid; 5 parts of nicotinamide; 3.5 parts of a penetrating humectant; 5 parts of rhamnose silanol; 10 parts of forest blue moistening lotion; 3 parts of rhamnose silanol; trehalose 0.3 parts, ophiopogon root extract 0.34 parts, prickly pear stem extract 0.35 parts, and flavescent sophora root extract 0.01 parts; 0.3 part of dihydrooat acyl anthranilic acid; 0.1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer; 0.1 part of PEG-40 hydrogenated castor oil.
The preparation method comprises the following steps
A1, mixing water and Glycyrrhrizae radix extract uniformly;
a2, mixing radix Angelicae sinensis extract, radix Salviae Miltiorrhizae extract, fructus Corni extract and fructus Lycii extract at room temperature;
a3, premixing 1, 2-pentanediol, nicotinamide and PEG-40 hydrogenated castor oil; and adding the mixture obtained in the step A1 and the step A2, mixing and stirring uniformly, then adding nonapeptide-1, carnosine, a rumex acetosa extract, ascorbic acid, nicotinamide, erythritol, sarcosine HCl, silanetriol, rhamnose, methyl propylene glycol, linlan dew, trehalose, a radix ophiopogonis extract, a prickly pear stem extract, a radix sophorae flavescentis extract, dihydroavenyl anthranilic acid and an acrylic acid (ester)/C12-22 alkanol methacrylate copolymer, stirring uniformly at normal temperature, standing for stabilization, and discharging.
Comparative example 3
50 parts of aloe extract; 0.5 part of angelica root extract; 0.5 part of dogwood fruit extract; 0.5 part of wolfberry root extract; 1 part of 1, 2-pentanediol; nonapeptide-18 parts; 2 parts of carnosine; 8.5 parts of nicotinamide; 3.5 parts of a penetrating humectant; 5 parts of rhamnose silanol; 10 parts of forest blue moistening lotion; 3 parts of rhamnose silanol; trehalose 0.3 parts, ophiopogon root extract 0.34 parts, prickly pear stem extract 0.35 parts, and flavescent sophora root extract 0.01 parts; 0.3 part of dihydrooat acyl anthranilic acid; 0.1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer; 0.1 part of PEG-40 hydrogenated castor oil.
The preparation method comprises the following steps
A1, mixing Aloe extract, radix Angelicae sinensis extract, Corni fructus extract and Lycii radix extract at room temperature;
a2, premixing 1, 2-pentanediol, nicotinamide and PEG-40 hydrogenated castor oil;
a3, adding the mixture of the step A1 and the step A2, mixing and stirring uniformly, then adding nonapeptide-1, carnosine, nicotinamide, erythritol, carnosine HCl, silanetriol, rhamnose, methyl propylene glycol, linlan emollient water, trehalose, an ophiopogon root extract, a twisted cactus stem extract, a sophora flavescens root extract, dihydroavenyl anthranilic acid and acrylic acid (ester)/C12-22 alkanol methacrylate copolymer, stirring uniformly at normal temperature, standing and discharging after stabilization.
Results of the experiment
1. The aloe extracts prepared in comparative example 1 and examples 1-2 were subjected to skin feel test; the results are shown in Table 1
TABLE 1 Aloe extract skin feeling test Table
Barbaloin content (mg/g) | Skin feel (trial for 20) | |
Comparative example 1 | 186 | Viscous (15 persons) |
Example 1 | 205 | Fresh and cool (19 persons) |
Example 2 | 203 | Fresh and cool (19 persons) |
The above table shows that the aloe extracts prepared in examples 1-2 are not sticky and give a refreshing skin feel.
2. The samples of example 3 and comparative example 3 were administered to 20 volunteers with similar skin conditions for 30 days, and used after cleansing in the morning and evening; the situation was recorded and the effect was followed after 15 days. (20 persons per group); the results are shown in Table 2.
Table 2 comparative table of skin condition after use of samples of example 3 and comparative example 3
As can be seen from the data in the table, the aloe extract has good relieving effect, and does not cause skin irritation and produce a reddening phenomenon. From the whitening data, the addition of the aloe extract also has a certain synergistic auxiliary effect on the whitening effect.
3. The samples of example 3 and comparative example 2 were administered to 20 volunteers with similar skin conditions for 30 days, and were used after cleansing in the morning and evening; the situation was recorded and the effect was followed after 15 days. (20 persons per group); the results are shown in Table 3.
Table 3 comparative table of skin condition after use of samples of example 3 and comparative example 2
As can be seen from the data in table 3, the total amount of the whitening agent used was 8.5 parts, but the whitening effect in example 3 was significantly better than that in comparative example 2. The combination of the whitening components of the invention has high whitening effect, and simultaneously reduces the irritation of the single whitening component nicotinamide.
4. Human body patch test
The essence prepared in example 3 of the present invention was tested by 35 volunteers according to the specifications of the skin patch test for human body described in the "standards for hygiene of cosmetics" (2007 edition), and the results are shown in the following table 4:
table 4 test record table for spot-sticking of human skin
As can be seen from the above table 4, the essence has no possibility of adverse reaction to human skin, which indicates that the formula of the essence is non-irritant and very safe.
5. And (3) evaluating the efficacy:
5.1 this efficacy evaluation entrusts third party testing company- -Guangdong Boxi Biotechnology Ltd to test
The experiment uses a 3D melanin skin modelThe in-vitro whitening effect of different sample groups is evaluated by three dimensional indexes of an apparent picture of a model after administration, the brightness (L value) of the skin model, the melanin content and the like.
From the day of model shipment (defined as day 0), UVB irradiation treatment (50mJ/cm2) is carried out every day, samples to be tested are evenly coated on the surface of a melanin model after continuous stimulation is carried out for 3 days, the dosage volume is 10 mu L/time, 1 time is carried out every 2 days, and the operation is finished after continuous stimulation is carried out for 4 days and is ready for use.
After the treatment of the administration mode is finished, the models of different experimental groups are subjected to apparent photographing observation. The photographing is carried out in a studio with fixed light intensity. The specific photographing standard operation is as follows: (1) a camera mode: manual operation; setting photographing parameters: focal length 5.8mm, aperture F/8, aperture F22, shutter speed 1/80s, ISO 3200. (2) And (4) placing the melanin model in the center of the colorimetric card for photographing.
L-value measurements were performed on the models of the different experimental groups. The specific detection standard operation is as follows: (1) cutting off the model along the edge ring of the small chamber by using a surgical blade; (2) and placing the model on a flat and hard white plane, vertically aligning a detection hole of the color difference meter with the surface of the model according to the use instruction of the color difference meter, detecting, repeatedly reading for three times for each model, and recording data.
The model to be tested adopts 0.6mL of 0.25% pancreatin, and is kept stand and digested for 2 hours at 37 ℃; after finishing, repeatedly blowing and beating the tissues for about 1min by using an elbow suction pipe; after the blowing is finished, taking out the separated PC film by using an elbow tweezers; and (4) terminating: adding 0.6mL of PBS containing 10% serum, centrifuging at 2000r/min for 10min, and removing the supernatant; adding 1N NaOH (containing 10% DMSO) into the precipitate, blowing and beating for several times, reacting in 80 deg.C water bath for 30min to completely dissolve melanin particles, centrifuging at 1200r/min for 5min, collecting supernatant, adding into 96-well plate, adding 200 μ L per well, and detecting OD value at ELISA reader A405nm
Fig. 1 to 3 are the apparent chromatograms of the blank control group, kojic acid and the essence of example 3, respectively, from which it can be seen that the apparent chromaticity of the essence is lighter than that of kojic acid, indicating that the whitening effect of the essence is better than that of kojic acid.
Fig. 4 is an evaluation of the apparent chromaticity of the control group with or without UVB irradiation and the treated serum, and it can be seen that the evaluation of the apparent chromaticity after the treated serum is almost higher than that of the treated serum which is irradiated only by UVB and is close to that of the treated serum which is not irradiated by UVB, which indicates that the serum has a very good whitening effect and can resist the pigmentation caused by UVB.
Fig. 5 shows the presence or absence of UVB irradiation, and the melanin content after kojic acid and serum treatment under UVB irradiation, and it can be seen that the melanin content after serum treatment is lower than that of kojic acid treatment, indicating that the whitening effect of the serum is better than that of kojic acid. The content of melanin after the treatment of the essence is even lower than that of melanin which is not subjected to UVB irradiation, and further shows that the essence has a good whitening effect.
5.2 type test-attorney Spectrum Nile Limited test, the results are as follows 5:
TABLE 5 type test result recording sheet
As can be seen from table 5 above, the essence of the present application meets the standards of skin care products.
The above description is only an embodiment of the present invention, and not intended to limit the scope of the present invention, and all modifications of equivalent structures and equivalent processes, which are made by the present specification, or directly or indirectly applied to other related technical fields, are included in the scope of the present invention.
Claims (8)
1. The polypeptide essence with the multiple-effect whitening effect is characterized by comprising the following raw materials in parts by weight:
50-80 parts of aloe extract;
0.5-1 part of reed extract;
0.5-1 part of licorice root extract;
0.5-1 part of angelica root extract;
0.5-1 part of salvia miltiorrhiza root extract;
0.5-1 part of dogwood fruit extract;
0.5-1 part of wolfberry root extract;
0.34-1.5 parts of radix ophiopogonis extract;
0.35-1.95% of the extract of the stem of the prickly pear;
0.01-0.05 part of sophora flavescens root extract;
1-3 parts of a rumex acetosa extract;
1-5 parts of 1, 2-pentanediol;
nonapeptide-12-8 shares;
0.1-2 parts of carnosine;
0.2-0.8 part of ascorbic acid;
2-5 parts of nicotinamide;
3-5 parts of a penetrating humectant;
2-10 parts of a forest blue lotion;
3-6 parts of rhamnose silanol;
0.3-1.5 parts of trehalose;
0.1-2 parts of dihydrooat acyl anthranilic acid;
0.1-1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer;
0.1-1 part of PEG-40 hydrogenated castor oil.
2. The polypeptide essence with the multi-effect whitening effect according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 68.1 parts of aloe extract, 1 part of reed extract, 1 part of licorice root extract, 1 part of angelica root extract, 1 part of salvia miltiorrhiza root extract, 1 part of dogwood fruit extract, 1 part of wolfberry root extract, 0.7 part of radix ophiopogonis extract, 1 part of rumex acetosa extract, 0.6 part of twisted cactus stem extract, 0.02 part of sophora flavescens ait root extract, 3 parts of 1, 2-pentanediol, nonapeptide-16 parts, 2 parts of carnosine, 0.3 part of ascorbic acid, 3 parts of nicotinamide, 3 parts of osmotic humectant, 2 parts of linlan lotion, 3 parts of rhamnose silanol, 0.8 part of trehalose, 1 part of dihydroavenoyl anthranilic acid, 0.1 part of acrylic acid (ester)/C12-22 alkanol methacrylate copolymer and 0.1 part of PEG-40 hydrogenated castor oil.
3. The polypeptide essence with multi-effect whitening effect according to claim 1, wherein: the rhamnosilanol is a mixture of 0.3 parts by weight of silanetriol, 2.35 parts by weight of rhamnose and 20 parts by weight of methylpropanediol.
4. The polypeptide essence with multi-effect whitening effect according to claim 1, wherein: the permeable humectant is a mixture of erythritol and creatinine HCl, and the mass ratio of the erythritol to the creatinine HCl is 100: 1.
5. The polypeptide essence with the multi-effect whitening effect according to claim 1, further comprising 0.1-1 weight part of a mixture of artemisia capillaris flower extract, clove flower extract and glyceryl caprylate; the mass ratio of the artemisia capillaris flower extract to the clove flower extract to the glyceryl caprylate is 20-25: 10-15: 3-5.
6. The polypeptide essence with multi-effect whitening effect according to claim 1, wherein the aloe extract is prepared by the following steps:
s1, selecting ripe aloe, cleaning, and pulping in a sealed environment;
s2, adding 5-8 times of 85-98% 1, 3-propylene glycol solution as solvent into the aloe pulp, performing ultrasonic treatment at 35-45 deg.C for 20min, and filtering to obtain the first filtrate;
s3, adding 10 parts by weight of distilled water into the obtained filter residue, adding degrading enzyme, stirring uniformly, standing for 30min, and filtering to obtain a second filtrate;
s4, mixing the first filtrate and the second filtrate, and mixing to obtain the aloe extract.
7. The polypeptide essence with multi-effect whitening effect according to claim 6, wherein: the degrading enzyme is a mixture of 0.15-0.2 weight parts of cellulase, 0.023-0.028 weight parts of pectinase and 0.015-0.018 weight parts of amylase.
8. The preparation method of the polypeptide essence with multi-effect whitening effect according to claim 1, which comprises the following steps:
a1, mixing Aloe extract, Phragmites communis extract and Glycyrrhrizae radix extract;
a2, mixing radix Angelicae sinensis extract, radix Salviae Miltiorrhizae extract, fructus Corni extract and fructus Lycii extract at room temperature;
a3, premixing 1, 2-pentanediol, nicotinamide and PEG-40 hydrogenated castor oil; and adding the mixture obtained in the step A1 and the step A2, mixing and stirring uniformly, adding nonapeptide-1, carnosine, a rumex acetosa extract, ascorbic acid, a penetrating humectant, a linlan lotion, rhamnose silanol, trehalose, a radix ophiopogonis extract, a twisted cactus stem extract, a sophora flavescens root extract, dihydroavenyl anthranilic acid and an acrylic acid (ester)/C12-22 alkanol methacrylate copolymer, stirring uniformly at normal temperature, standing stably and discharging.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911040758.7A CN110664643A (en) | 2019-10-30 | 2019-10-30 | Polypeptide essence with multiple-effect whitening effect and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911040758.7A CN110664643A (en) | 2019-10-30 | 2019-10-30 | Polypeptide essence with multiple-effect whitening effect and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110664643A true CN110664643A (en) | 2020-01-10 |
Family
ID=69084739
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911040758.7A Withdrawn CN110664643A (en) | 2019-10-30 | 2019-10-30 | Polypeptide essence with multiple-effect whitening effect and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110664643A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113143811A (en) * | 2020-12-14 | 2021-07-23 | 洛阳师范学院 | A kind of preparation method of peony flower extract complex liposome |
CN113318031A (en) * | 2021-06-21 | 2021-08-31 | 杭州友丽医疗科技(集团)有限公司 | Skin beautifying toner composition for removing chloasma, skin beautifying toner and preparation method thereof |
CN115350133A (en) * | 2022-08-29 | 2022-11-18 | 广东轻工职业技术学院 | Preparation and application of skin-whitening and soothing nano-structure lipid carrier |
CN118634168A (en) * | 2024-06-04 | 2024-09-13 | 广州梵之容化妆品有限公司 | A whitening and anti-aging composition, a whitening and anti-aging cream and a preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106237029A (en) * | 2016-08-26 | 2016-12-21 | 吉安市御美丽健康产业股份有限公司 | A kind of aloe antibiotic gel and preparation method thereof |
CN106361599A (en) * | 2016-08-31 | 2017-02-01 | 福建省梦娇兰日用化学品有限公司 | Multi-vegetable-oil-containing infantile eczema care cream |
CN106880565A (en) * | 2017-03-03 | 2017-06-23 | 北京华奥光程化妆品有限公司 | A kind of plant extracts for the light spot of skin-whitening and its preparation method and application |
CN109453095A (en) * | 2018-11-26 | 2019-03-12 | 广州秉科医药科技有限公司 | A kind of niacinamide stoste and preparation method thereof |
CN110384653A (en) * | 2019-09-06 | 2019-10-29 | 奢脉国际化妆品(北京)有限公司 | It is a kind of to have effects that the multi-faceted polypeptide Essence for dispelling yellow and its preparation process |
-
2019
- 2019-10-30 CN CN201911040758.7A patent/CN110664643A/en not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106237029A (en) * | 2016-08-26 | 2016-12-21 | 吉安市御美丽健康产业股份有限公司 | A kind of aloe antibiotic gel and preparation method thereof |
CN106361599A (en) * | 2016-08-31 | 2017-02-01 | 福建省梦娇兰日用化学品有限公司 | Multi-vegetable-oil-containing infantile eczema care cream |
CN106880565A (en) * | 2017-03-03 | 2017-06-23 | 北京华奥光程化妆品有限公司 | A kind of plant extracts for the light spot of skin-whitening and its preparation method and application |
CN109453095A (en) * | 2018-11-26 | 2019-03-12 | 广州秉科医药科技有限公司 | A kind of niacinamide stoste and preparation method thereof |
CN110384653A (en) * | 2019-09-06 | 2019-10-29 | 奢脉国际化妆品(北京)有限公司 | It is a kind of to have effects that the multi-faceted polypeptide Essence for dispelling yellow and its preparation process |
Non-Patent Citations (6)
Title |
---|
五月: "美白祛黑膜", 《HTTPS://WWW.MEIPIAN.CN/1VCDQPDH》 * |
名美妆: "奢脉产品获中国权威检测机构(中国日化院)高度认可", 《HTTPS://WWW.163.COM/DY/ARTICLE/EMV6UHNF05149MLS.HTML》 * |
奢脉国际化妆品(北京)有限公司: "奢脉均衡靓肤多肽精华液", 《HTTP://FTBA.NMPA.GOV.CN:8181/FTBAN/ITOWNET/HZP_BA/NEW_INFO/CHANGE_DZPZ.JSP?PROCESSID=20190808123325PXDG3&BA_PARAM=MJAXOS0WNI0XMQ==》 * |
范青生: "《保健食品工艺学》", 30 November 2006, 中国医药科技出版社 * |
蕊颜实验室: "给大家科普一下什么是林兰润露?", 《HTTPS://WEIBO.COM/7256836898/I2SVVHRKN?TYPE=COMMENT》 * |
谭伟等: "《灵芝生物学及生产新技术》", 30 April 2007, 中国农业科学技术出版社 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113143811A (en) * | 2020-12-14 | 2021-07-23 | 洛阳师范学院 | A kind of preparation method of peony flower extract complex liposome |
CN113143811B (en) * | 2020-12-14 | 2023-01-24 | 洛阳师范学院 | A kind of preparation method of peony flower extract composite liposome |
CN113318031A (en) * | 2021-06-21 | 2021-08-31 | 杭州友丽医疗科技(集团)有限公司 | Skin beautifying toner composition for removing chloasma, skin beautifying toner and preparation method thereof |
CN115350133A (en) * | 2022-08-29 | 2022-11-18 | 广东轻工职业技术学院 | Preparation and application of skin-whitening and soothing nano-structure lipid carrier |
CN118634168A (en) * | 2024-06-04 | 2024-09-13 | 广州梵之容化妆品有限公司 | A whitening and anti-aging composition, a whitening and anti-aging cream and a preparation method thereof |
CN118634168B (en) * | 2024-06-04 | 2025-04-11 | 谷雨生物科技集团股份有限公司 | A whitening and anti-aging composition, a whitening and anti-aging cream and a preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111714425B (en) | Shampoo composition for improving scalp and hair condition | |
CN110664643A (en) | Polypeptide essence with multiple-effect whitening effect and preparation method thereof | |
CN102641233B (en) | Rhodiola crenulata facial mask with whitening and moisturizing effects | |
CN103976905B (en) | A kind of plant extract liquid mixture with anti-inflammatory anti-allergic effects | |
CN103932970A (en) | Chinese herbal medicine freckle-removal compound cosmetic and preparation method thereof | |
CN106265164B (en) | With hair tonic, scalp maintenance, the composition of moisture-keeping efficacy and preparation method thereof | |
CN104784507A (en) | Traditional Chinese medicine composition with multiple cosmetic effects and application | |
CN113288853A (en) | Natural composition tincture for nourishing hair follicles, preventing alopecia, promoting hair growth, resisting inflammation and resisting bacteria and preparation method thereof | |
CN111012725A (en) | Asparagus skin care composition and preparation method thereof | |
CN108938493A (en) | A kind of Chinese medicine composition and its preparation method and application | |
CN110859791B (en) | Skin whitening composition and its application, skin whitening mask | |
CN110420150A (en) | A kind of anti-aging skin care product composition containing Moringa seed extract | |
CN110755358A (en) | Five-nourishing angelica-source Chinese herbal medicine hair nourishing composition and preparation thereof | |
CN110090191A (en) | A kind of after-sun recovery composition and its cosmetics | |
CN114983914A (en) | Preparation method of whitening skin care product | |
CN106176515A (en) | A kind of body whitening crème and preparation method thereof | |
CN110604718A (en) | Full-effect polypeptide eye essence and preparation method thereof | |
CN112043661B (en) | Whitening aloe gel and preparation method thereof | |
CN108670933B (en) | Skin care composition with moisturizing, whitening and anti-aging functions and application thereof | |
CN107898749B (en) | A topical composition with skin caring effect and its preparation method | |
CN111658558A (en) | Traditional Chinese medicine freckle-removing essence and preparation method thereof | |
CN106539747B (en) | A kind of face mask for eliminating macula and whitening skin and preparation method thereof | |
CN112107522A (en) | Whitening composition, whitening mask and preparation method thereof | |
CN102327200A (en) | Whitening and freckle-removing product and preparation method thereof | |
CN111759919A (en) | Freckle-removing traditional Chinese medicine composition and preparation method thereof, freckle-removing traditional Chinese medicine face cream and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200110 |
|
WW01 | Invention patent application withdrawn after publication |